Submission is supported by 48-week results from the Phase 3 GALAXI and GRAVITI programs TREMFYA® is the only IL-23 inhibitor to demonstrate strong endoscopic outcomes with subcutaneous (SC) induction, consistent… Read More
Genome British Columbia is pleased to announce the appointment of Dr. Mel Krajden to our Board of Directors Dr. Mel Krajden is a Medical Microbiologist researcher at the BC Centre for… Read More
Asees Kaur of Victoria’s VoxCell was declared the winner of the 2024 edition of PITCH in front of a full Centre Stage crowd today. PITCH is Collision’s startup competition that brings together the world’s… Read More
CHARLOTTETOWN, PE – Together with the Future Skills Centre (FSC), the Canadian Alliance for Skills and Training in Life Sciences (CASTL) has launched a national biomanufacturing skills and training study to… Read More
The BCIT MAKE+ applied research group is collaborating with Providence Health Care (PHC) through Providence Research’s annual Skunkworks innovation competition. This collaboration is aimed at inspiring and developing new medical devices and health-related technologies, driven directly by insights… Read More
